Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Rebif. Always confirm against the full prescribing information.
100 interactions
Abacavir
The risk or severity of liver damage can be increased when Interferon beta-1a is combined with Abacavir.
Level 2 evidence
Abatacept
The risk or severity of liver damage can be increased when Interferon beta-1a is combined with Abatacept.
Level 2 evidence
Abemaciclib
The risk or severity of liver damage can be increased when Interferon beta-1a is combined with Abemaciclib.
Level 2 evidence
Abiraterone
The risk or severity of liver damage can be increased when Interferon beta-1a is combined with Abiraterone.
Level 2 evidence
Acalabrutinib
The risk or severity of liver damage can be increased when Interferon beta-1a is combined with Acalabrutinib.
Level 2 evidence
Acamprosate
The risk or severity of liver damage can be increased when Interferon beta-1a is combined with Acamprosate.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Interferon beta-1a is combined with Acarbose.
Level 2 evidence
Acebutolol
The risk or severity of liver damage can be increased when Interferon beta-1a is combined with Acebutolol.
Level 2 evidence
Aceclofenac
The risk or severity of liver damage can be increased when Interferon beta-1a is combined with Aceclofenac.
Level 2 evidence
Acetaminophen
The metabolism of Acetaminophen can be decreased when combined with Interferon beta-1a.
Level 2 evidence
Acetazolamide
The risk or severity of liver damage can be increased when Interferon beta-1a is combined with Acetazolamide.
Level 2 evidence
Acetohydroxamic acid
The risk or severity of liver damage can be increased when Interferon beta-1a is combined with Acetohydroxamic acid.
Level 2 evidence
Enter your NPI to unlock 5 major interactions for Rebif
Rebif (Interferon Beta-1a) has 873 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Rebif (Interferon Beta-1a) has 22 major, 848 moderate, and 3 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Rebif. Always confirm against the full prescribing information.